Using PIVO for blood cultures in the ER
Part of Infections clinical trials.
This trial tests a device called PIVO that may make it easier and less painful to draw blood for blood cultures in the emergency room. It's for anyone in the ER who needs this test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child are in the emergency room.
- A doctor has ordered a blood culture test (a test to check for infection in the blood).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized approach to giving IV fluids to patients with sepsis in the emergency department. It uses a device to monitor your heart and blood flow to help doctors decide how much fluid you need, which may improve recovery.
This trial tests a new way to draw blood for infection testing using ultrasound to guide the needle. It may help make blood draws easier and safer for critically ill patients in the ICU.
This study tests a new blood test that may quickly find bacteria or yeast causing a bloodstream infection. It uses a small extra blood sample taken at the same time as your regular blood culture, and could help doctors identify the infection faster.
This trial is testing a new method (IDBIORIV) to quickly identify the germs causing sepsis and find the right antibiotic. It aims to help patients with a confirmed bloodstream infection get the most effective treatment faster.
This trial tests a new treatment to protect and repair the layer of cells lining your blood vessels (glycocalyx) during sepsis. It aims to improve recovery from severe infections.
This trial tests a new rapid test that can quickly identify the cause of a severe infection (sepsis) in ICU patients. The goal is to see if faster results help doctors choose the right treatment sooner.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.